The first annual Life Sciences Leadership Gala is an invitation-only event that will gather the leaders who are making Washington one of the country’s most successful life science clusters. This gala, under the stars in the Atrium at 188 East Blaine, will bring together CEOs and senior executives from our top companies, founders and entrepreneurs from emerging companies, investors, and the people working with our LSW Institute to help grow the next generation of life science companies across the state. The event will include the release of a new investor report, highlights on company accomplishments, an award ceremony, a dessert reception, and ample time to network and connect with the prominent trailblazers in our community.
This must-attend event is by invitation only for CEOs and senior executives.
If you have any questions regarding registration for this event, please contact Kathleen Poston at firstname.lastname@example.org.
COVID SAFETY INFORMATION
As the COVID-19 global pandemic continues, Life Science Washington is both cautiously optimistic and prepared to manage our in-person events with the health, safety, and well-being of our attendees, staff, presenters, sponsors, and speakers in mind. Life Science Washington expects all participants to comply with current CDC, state, and local COVID-19 related guidelines, rules, and requirements as they continue to evolve. Mask wearing is encouraged, though not required.
- If you have tested positive for COVID-19, are still within your quarantine or isolation time and have not since received a negative COVID-19 test result, please do not attend.
- If you’re experiencing any COVID-19 symptoms (such as muscle or body aches, fever, cough, sore throat, runny or stuffy nose, etc.) within 5 days of the event, please test yourself, before considering attending.
- If you have been in close contact* with someone who has tested positive or is suspected to have COVID-19, and 10 days has not passed since your contact, please do not attend.
*Close contact means being within 6 feet of an infected/symptomatic person for at least 15 minutes cumulatively over a 24-hour period (starting 48 hours before the symptomatic person’s onset of illness or 48 hours before the asymptomatic person’s lab specimen collection until the person meets criteria for discontinuing their isolation).